Towards a circular economy for the plastic packaging sector: Insights from the Italian case

Achieving a circular economy (CE) has become a strategic priority for the plastic packaging industry to imple-ment long-term business sustainability while meeting legislative requirements. In this view, the evolution of cir-cularity practices in relation to technological, regulatory, and socio-economic factors and the implications for different value chain actors are open streams of research. This study aims to assess trends and meaningful changes in the adoption of circularity practices from the perspective of different value chain actors, under the ef-fects of leading CE barriers and enablers. A longitudinal analysis of the influence of these factors in relation to CE practices adopted by the Italian plastic packaging sector was conducted for the years 2011, 2015, and 2019. The involvement in plastic recovery became a predominant CE strategy over time, thanks to technological availability and a more mature regulatory framework. Our results suggest a gradual shift from scattered CE implementations to a more systemic approach to CE integrating upstream and downstream solutions. However, this transition oc-curred at different speeds and levels across the supply chain, as companies perceived factors differently and, con-sequently, implemented different types of CE practices. Therefore, increased collaboration and alignment across the supply chain are still required to overcome existing challenges. Based on our analysis, a focus group with stakeholders and experts of the plastic industry drew possible future avenues for the plastic packaging sector. Suggested priority actions include advancement of new and emerging recycling technologies, prioritization of economically viable and closed-loop alternatives to recover plastic waste, and alignment between national and international CE directives. These results extend our understanding of the CE transition and shed new light on the ways in which the industry can address existing barriers in different tiers for a system-wide impact. (c) 2022 Institution of Chemical Engineers. Published by Elsevier Ltd. All rights reserved

Targeting the MET oncogene by concomitant inhibition of receptor and ligand via an antibody-“decoy” strategy

MET, a master gene sustaining "invasive growth," is a relevant target for cancer precision therapy. In the vast majority of tumors, wild-type MET behaves as a "stress-response" gene and relies on the ligand (HGF) to sustain cell "scattering," invasive growth and apoptosis protection (oncogene "expedience"). In this context, concomitant targeting of MET and HGF could be crucial to reach effective inhibition. To test this hypothesis, we combined an anti-MET antibody (MvDN30) inducing "shedding" (i.e., removal of MET from the cell surface), with a "decoy" (i.e., the soluble extracellular domain of the MET receptor) endowed with HGF-sequestering ability. To avoid antibody/decoy interaction-and subsequent neutralization-we identified a single aminoacid in the extracellular domain of MET-lysine 842-that is critical for MvDN30 binding and engineered the corresponding recombinant decoyMET (K842E). DecoyMET(K842E) retains the ability to bind HGF with high affinity and inhibits HGF-induced MET phosphorylation. In HGF-dependent cellular models, MvDN30 antibody and decoyMET(K842E) used in combination cooperate in restraining invasive growth, and synergize in blocking cancer cell "scattering." The antibody and the decoy unbridle apoptosis of colon cancer stem cells grown in vitro as spheroids. In a preclinical model, built by orthotopic transplantation of a human pancreatic carcinoma in SCID mice engineered to express human HGF, concomitant treatment with antibody and decoy significantly reduces metastatic spread. The data reported indicate that vertical targeting of the MET/HGF axis results in powerful inhibition of ligand-dependent MET activation, providing proof of concept in favor of combined target therapy of MET "expedience.

Mechanical support concept of the DEMO breeding blanket

The DEMO tokamak architecture is based on large vertical breeding blanket (BB) segments that are accessed from a maintenance hall above the tokamak and are vertically replaced through large upper ports of the vacuum vessel (VV). The feasibility of the BB segments mechanical supports is a prerequisite of this vertical segment architecture. Their design directly impacts on the removal kinematics and the remote handling operations required for release and engagement. The supports must withstand large forces acting on the BB in particular due to electromagnetic (EM) loads. At the same time, they must ensure a sufficiently precise positioning of the BB first wall. Their design also takes into account the significant thermal expansion of the blanket segments that are operated at high temperature avoiding excessive support reaction forces. The BB support concept described in this article does not require fasteners or electrical straps to the VV and therefore much reduces the complexity of the BB remote replacement – a valuable characteristic that would make this concept a milestone in meeting one of the goals defined for the DEMO project: to develop a maintainable fusion power plant design [1]. Each blanket segment is individually supported by the VV without any physical contact to the other blankets or in-vessel components. It relies instead on vertical pre-compression inside the VV due to obstructed thermal expansion and radial pre-compression due to the ferromagnetic force acting on the BB material in the toroidal magnetic field. The verification process did not identify show stoppers. Nonetheless, a further evolution of the concept is required including design improvements to mitigate the high stress levels found in the inboard blankets during plasma disruptions. The fact that no excessively high support reaction forces or large BB deflections were found suggests though that the further development of the concept could be successful

Multidisciplinary approach for a relapsing goiter with severe tracheal stenosis: a case report in an elderly patient

Total thyroidectomy is considered the gold standard for thyroid benign pathology treatment. Unfortunately, many partial interventions carried out in the past created many complications due to the tendency of the goiter to relapse and the formation of adherences in the anterior region of the neck. A woman 72 years of age with a relapsing goiter and severe respiratory symptomatology underwent thyroidectomy. After thyroid removal, tracheal stenosis persisted, making the positioning of a T silicon prosthesis (Montgomery’s T-tube) necessary. After 60 days, the prosthesis was replaced with a new made out of the same material but with a larger diameter and a softer consistency, which was removed after 4 months. The patient completely recovered her respiratory function and also maintained normal vocal cord activity without any kind of surgical sequelae. The full success was possible because of the involvement of different specialists

Intraoperative measurement of parathyroid hormone: A Copernican revolution in the surgical treatment of hyperparathyroidism

Intraoperative parathyroid hormone (PTH) monitoring in the setting of the operating room represents a valuable example of the rationale use of the laboratory diagnostic in a patient-oriented approach. Rapid intraoperative PTH (ioPTH) assay is a valid tool for an accurate evaluation of the success of parathyroid surgery. The reliability of the user-friendly portable systems as well as the collaboration between operators and surgical staff allow the one-site monitoring of the ioPTH decrements on the course of the surgical management of hyperparathyroidism.The rapid answer provided by an effective decrement of PTH during parathyroidectomy contributes dramatically to the efficacy of parathyroid surgery and the reduction of the number of re-operations. Therefore the dose of ioPTH is a valid and reliable support for the success of the intervention of parathyroidectomy at controlled costs

Molecular mechanism of tanshinone IIA and cryptotanshinone in platelet anti-aggregating effects: an integrated study of pharmacology and computational analysis.

Tanshinone IIA and cryptotanshinone are two pharmacologically active diterpenoids extracted from the roots of Salvia milthiorriza Bunge, a plant used in Chinese traditional medicine for the treatment of some cardiovascular and cerebrovascular disease. Until now, the molecular mechanisms of action of these two diterpenoids on platelets are partially known. To clarify this aspect, here we utilized an integrated study of pharmacology and computational analysis. Our results demonstrate that cryptotanshinone is able to inhibit in a concentration dependent manner the rat platelet aggregation and also is endowed of Gi-coupled P2Y12 receptor antagonist as demonstrated by docking studies. This computational method was also performed for tanshinone IIA demonstrating even for this diterpenoid an interaction with the same receptor. The findings from our study enable a better understanding of tanshinone IIA and cryptotanshinone biological properties, which could ultimately lead to the development of novel pharmaceutical strategies for the treatment and/or prevention of some cardiovascular disease

Statistics of fractional moments applied to 3D video streams

© 2014 IEEE. The interest in processing three-dimensional (3D) videos is ever increasing because of the exponential growth of sophisticated devices supporting 3D streams. However, transmitting compressed 3D videos on channels with relatively limited bandwidth resources is a challenging research problem, because of the high variability of 3D streams. A stable and robust characterization of the statistical properties of 3D videos could be very useful for several applications (bandwidth management and control by effective schedulers/controllers, call admission control schemes, etc.). This work proposes a straightforward characterization method, based on the statistics of fractional moments. The properties of long sequences of 3D videos are reduced to a very small set of fitting parameters, constituting the video 'fingerprint'. The method is applied to a set of videos, with different compression degrees. Moreover, possible similarities among different fingerprints are investigated for an effective 3D video classification

Calcium as a key player in arrhythmogenic cardiomiopathy : adhesion disorder or intracellular alteration?

Arrhythmogenic cardiomyopathy (ACM) is an inherited heart disease characterized by sudden death in young people and featured by fibro-adipose myocardium replacement, malignant arrhythmias, and heart failure. To date, no etiological therapies are available. Mutations in desmosomal genes cause abnormal mechanical coupling, trigger pro-apoptotic signaling pathways, and induce fibro-adipose replacement. Here, we discuss the hypothesis that the ACM causative mechanism involves a defect in the expression and/or activity of the cardiac Ca2+ handling machinery, focusing on the available data supporting this hypothesis. The Ca2+ toolkit is heavily remodeled in cardiomyocytes derived from a mouse model of ACM defective of the desmosomal protein plakophilin-2. Furthermore, ACM-related mutations were found in genes encoding for proteins involved in excitation\u2012contraction coupling, e.g., type 2 ryanodine receptor and phospholamban. As a consequence, the sarcoplasmic reticulum becomes more eager to release Ca2+, thereby inducing delayed afterdepolarizations and impairing cardiac contractility. These data are supported by preliminary observations from patient induced pluripotent stem-cell-derived cardiomyocytes. Assessing the involvement of Ca2+ signaling in the pathogenesis of ACM could be beneficial in the treatment of this life-threatening disease